Veracyte's Shares Rise Sharply in December, but MDx/Omics Tools Stocks Decline Slightly | GenomeWeb

NEW YORK (GenomeWeb) – Shares of Veracyte were up 48 percent month over month in December pacing the gainers in the GenomeWeb Daily News Index, which overall was essentially flat during the month. 

The GWDN Index was down a fraction of 1 percent from November despite the large gain by Veracyte, as well as significant jumps in the shares of Vermillion (+26 percent), Sequenom (+23 percent), and GenMark Diagnostics (+20 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.